Alvotech (ICE:ALVO)
1,240.00
-70.00 (-5.34%)
At close: Jun 11, 2025
Alvotech Revenue
Alvotech had revenue of $132.81M USD in the quarter ending March 31, 2025, with 259.97% growth. This brings the company's revenue in the last twelve months to $587.89M, up 413.92% year-over-year. In the year 2024, Alvotech had annual revenue of $491.98M with 426.84% growth.
Revenue (ttm)
$587.89M
Revenue Growth
+413.92%
P/S Ratio
5.10
Revenue / Employee
$580.92K
Employees
1,012
Market Cap
395.80B ISK
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Marel | 250.20B |
Íslandsbanki | 62.96B |
Arion banki | 61.68B |
Sildarvinnslan Hf. | 43.52B |
Brim hf. | 58.07B |
Hagar | 177.12B |
Kvika banki | 15.14B |
Festi | 147.75B |
Alvotech News
- 5 days ago - Alvotech Participates in the Goldman Sachs Global Healthcare Conference in Miami - GlobeNewsWire
- 5 days ago - Alvotech Meets Investors and Presents at the Goldman Sachs Global Healthcare Conference in Miami - GlobeNewsWire
- 6 days ago - Dr Reddy's And Alvotech Join Hands To Develop Biosimilar For Merck's Blockbuster Cancer Drug - Benzinga
- 7 days ago - Alvotech has carried out a private placement of 7,500,000 SDRs and ordinary shares at a price of SEK 100.00 per SDR and ISK 1320.83 per ordinary share, raising gross proceeds of SEK 750 million - GlobeNewsWire
- 7 days ago - Alvotech has carried out a private placement of 7,500,000 SDRs and ordinary shares at a price of SEK 100.00 per SDR and ISK 1320.83 per ordinary share, raising gross proceeds of SEK 750 million - GlobeNewsWire
- 7 days ago - Alvotech intends to carry out a private placement of approximately 7.5 million SDRs and ordinary shares - GlobeNewsWire
- 7 days ago - Alvotech Completes Acquisition of Xbrane R&D Organization and biosimilar candidate to Cimzia® - GlobeNewsWire
- 9 days ago - Alvotech Meets Investors and Presents at the Jefferies Global Healthcare Conference 2025 in New York, NY - GlobeNewsWire